H
Haitang Yang
Researcher at Shanghai Jiao Tong University
Publications - 65
Citations - 1061
Haitang Yang is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 16, co-authored 53 publications receiving 611 citations. Previous affiliations of Haitang Yang include University of Bern.
Papers
More filters
Journal ArticleDOI
New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness.
TL;DR: An update on the most recent advances in KRAS-mutant lung cancer is provided, with a focus on mechanistic insights into tumor heterogeneity, the potential clinic implications and new therapies on horizons tailored for KRas-mutants lung cancer.
Journal ArticleDOI
EGFR tyrosine kinase inhibitor (TKI) in patients with advanced non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations: A real-world study in China
Jianlin Xu,Bo Jin,Tianqing Chu,Xue Dong,Haitang Yang,Yanwei Zhang,Dan Wu,Yuqing Lou,Xueyan Zhang,H. Wang,Baohui Han +10 more
TL;DR: These results suggest that EGFR TKI therapy is effective in patients with L861Q/G719X/Del-19+L858R/del-19 or L858-R+other mutations; less effective in Patients with 20ins/Del, 19 or L 858R+T790M.
Journal ArticleDOI
p54(nrb)/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A.
Zhiyong Zhu,Xin Zhao,Li Zhao,Haitang Yang,Liu Liu,Jia Li,Jun Wu,Fajun Yang,Gang Huang,Jianjun Liu +9 more
TL;DR: It is shown that the nuclear protein p54nrb/Nono is highly expressed in breast cancer tissues as compared with the adjacent normal tissues in human patients, and the SREBP pathway may represent a novel target for treating breast cancer.
Journal ArticleDOI
Prophylactic Cranial Irradiation for Patients with Surgically Resected Small Cell Lung Cancer.
Jianlin Xu,Haitang Yang,Xiaolong Fu,Bo Jin,Yuqing Lou,Yanwei Zhang,Xueyan Zhang,H. Zhong,Huimin Wang,Dan Wu,Baohui Han +10 more
TL;DR: The data presented in the current study support using PCI in patients with p‐stage II/III disease but not in patients of completely resected SCLC, suggesting a relatively lower risk for brain metastases in p-stage I patients might explain the inferior efficacy of PCI in this population.
Journal ArticleDOI
Surgical Therapy for Bilateral Multiple Primary Lung Cancer.
TL;DR: The prognosis of patients after bilateral surgical treatment with curative intent for bilateral multiple primary lung cancer was shown to be promising and postoperative pathologic diagnosis classified by the most advanced TNM had a good correlation with prognosis in patients with BMPLC.